The logistic organ dysfunction score as a tool for making ethical decisions

Area of Science:

• Critical Care Medicine
• Prognostic Biomarkers
• Intensive Care Unit Outcomes

Background:

• Assessing patient prognosis in the ICU is crucial for clinical decision-making.
• Therapeutic limitations (TL) decisions require reliable predictive tools.
• The logistic organ dysfunction (LOD) score is a measure of organ dysfunction.

Purpose of the Study:

• To determine if the change in LOD between the first and fourth day in the ICU (DeltaLOD) predicts mortality.
• To evaluate DeltaLOD's utility in guiding therapeutic limitation decisions.

Main Methods:

• 154 patients were initially included; 93 remained after exclusions (ICU discharge or TL before 72 hours).
• LOD was calculated on admission (LOD1) and between 72-96 hours (LOD4).
• DeltaLOD (LOD4-LOD1) was analyzed for association with mortality, calculating sensitivity, specificity, PPV, and NPV.

Main Results:

• Patients who died in the ICU had a significantly higher DeltaLOD compared to survivors (P=0.0046).
• Logistic regression showed high DeltaLOD independently predicted ICU death, irrespective of initial disease severity.
• A DeltaLOD cutoff of >= 4 had a positive predictive value (PPV) of 0.66 for ICU death; a cutoff of >= 1 had a negative predictive value (NPV) of 0.89.

Conclusions:

• DeltaLOD is a significant predictor of ICU mortality, independent of initial disease severity.
• While the NPV of DeltaLOD is useful for identifying low-risk patients, its PPV is insufficient for individual therapeutic limitation decisions.
• Further evaluation of DeltaLOD in more severely ill patient populations is warranted.